Aripiprazole

Category
Neuroleptic
Product code
129722-12-9

Aripiprazole is a well-established atypical antipsychotic active pharmaceutical ingredient (API) recognized for its effectiveness in treating a spectrum of psychiatric conditions, including schizophrenia, bipolar disorder, and major depressive disorder. By modulating both dopaminergic and serotonergic pathways in the central nervous system, Aripiprazole addresses core symptoms such as hallucinations, delusions, mood instability, and agitation. Pharmaceutical companies formulate Aripiprazole into oral tablets, oral solutions, and long-acting injectable forms, providing flexible dosing strategies and sustained therapeutic benefits to enhance patient adherence and clinical outcomes.

Common Aripiprazole Uses and Treated Conditions

  • Schizophrenia – Reduces hallucinations, delusions, and disorganized thinking.
  • Bipolar Disorder – Treats manic and mixed episodes and serves as maintenance therapy.
  • Major Depressive Disorder (Adjunct) – Used as adjunctive treatment in adults with major depressive disorder.
  • Irritability Associated with Autism – Approved for treating irritability in pediatric patients with autism spectrum disorder.

Why Choose Cambrex as Your Generic API Manufacturer?

As a leading generic API supplier, Cambrex manufactures Aripiprazole API in cGMP-compliant facilities, ensuring every batch meets stringent global quality and regulatory standards. Our technical expertise, robust quality systems, and proven regulatory track record empower clients to accelerate development timelines and achieve successful market approvals. We prioritize transparency, reliability, and scientific rigor at every stage of the supply chain making us your trusted generic API manufacturer.

For detailed chemical information on Albuterol, visit the official CAS webpage.

If you’d like more information or to request a sample, contact our Generic API team today.

Aripiprazole

Cambrex your API partner

Cambrex are a leading global supplier of generic APIs. From our sites in Italy, Sweden, and the USA, we work with generic drug companies well in advance of drug patent expiration, using high quality, non-patent-infringing processes to manufacture APIs.

Contact us